NG2 and PDGFRα are key factors for cellular proliferation and motility. PDGF expression supports tumoral development of GBM, while amplification of PDGFRα significantly promotes tumoral aggressive behavior and is correlated to ATRX loss. The gene discussed is CSPG4; the disease is glioblastoma.